Abiomed
ABMD
#1109
Rank
NZ$29.41 B
Marketcap
$652.27
Share price
0.00%
Change (1 day)
N/A
Change (1 year)
Categories
Abiomed is an American medical devices company that develops and manufactures the circulatory support device Impella, the worldโ€™s smallest heart pump.

Abiomed (ABMD) - Total liabilities

Total liabilities on the balance sheet as of September 2022 : NZ$0.26 Billion

According to Abiomed's latest financial reports the company's total liabilities are NZ$0.26 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Abiomed - Total liabilities on balance sheet (from 2013 to 2022)

Total liabilities by year

Year Total liabilities Change
2022-03-31NZ$0.24 B3.59%
2021-03-31NZ$0.23 B-6.26%
2020-03-31NZ$0.25 B45.5%
2019-03-31NZ$0.17 B29.09%
2018-03-31NZ$0.13 B-4.73%
2017-03-31NZ$0.14 B75.74%
2016-03-31NZ$79.89 M28.05%
2015-03-31NZ$62.39 M45.99%
2014-03-31NZ$42.74 M8.7%
2013-03-31NZ$39.32 M16.89%
2012-03-31NZ$33.63 M-4.5%
2011-03-31NZ$35.22 M15.23%
2010-03-31NZ$30.57 M-14.27%
2009-03-31NZ$35.65 M14.53%
2008-03-31NZ$31.13 M58.13%
2007-03-31NZ$19.68 M33.57%
2006-03-31NZ$14.73 M115.12%
2005-03-31NZ$6.85 M-5.32%
2004-03-31NZ$7.23 M-35.86%
2003-03-31NZ$11.28 M-51.25%
2002-03-31NZ$23.14 M-1.55%
2001-03-31NZ$23.5 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
NZ$5.14 B 1,816.71%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$29.31 B 10,822.64%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.25 B-4.28%๐Ÿ‡บ๐Ÿ‡ธ USA